Campus Units
Biomedical Sciences, Veterinary Diagnostic and Production Animal Medicine
Document Type
Letter to the Editor
Publication Version
Published Version
Publication Date
1-27-2021
Journal or Book Title
Journal of Veterinary Internal Medicine
DOI
10.1111/jvim.16035
Abstract
The manuscript entitled Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial1 reports a study which sought to answer the question “could pimobendan be all that is needed beyond loop diuretics to manage congestive heart failure (CHF) in myxomatous mitral valve disease (MMVD)?” This was done by prospectively comparing the efficacy of pimobendan + ramipril + furosemide (triple treatment) to pimobendan + furosemide (double treatment) to treat new‐onset CHF caused by MMVD.
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License
Copyright Owner
The Authors
Copyright Date
2021
Language
en
File Format
application/pdf
Recommended Citation
Atkins, Clarke; Keene, Bruce; DeFrancesco, Teresa C.; Tou, Sandra; Chetboul, Valérie; Côté, Étienne; Ettinger, Stephen; Fox, Philip R.; Hamlin, Robert L.; Mochel, Jonathan P.; Pouchelon, Jean‐Louis; and Stepien, Rebecca L., "Letter to the editor regarding “Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial”" (2021). Biomedical Sciences Publications. 91.
https://lib.dr.iastate.edu/bms_pubs/91
Included in
Small or Companion Animal Medicine Commons, Veterinary Toxicology and Pharmacology Commons
Comments
This article is published as Atkins, Clarke, Bruce Keene, Teresa C. DeFrancesco, Sandra Tou, Valérie Chetboul, Étienne Côté, Stephen Ettinger, Philip R. Fox, Robert L. Hamlin, Jonathan P. Mochel, Jean‐Louis Pouchelon, and Rebecca L. Stepien. "Letter to the editor regarding" Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial"." Journal of Veterinary Internal Medicine (2021). DOI: 10.1111/jvim.16035. Posted with permission.